GLAXF Financials 07/16/2014 02:35:40 GlaxoSmithKl

GLAXF Financials 07/16/2014 02:35:40
GlaxoSmithKline plc
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 43,899,000 42,964,000 42,563,000 44,452,000
Cost of Revenue 14,219,000 12,882,000 11,925,000 12,366,000
Gross Profit 29,680,000 30,082,000 30,638,000 32,087,000
Operating Expenses
Research and Development 6,498,000 6,468,000 6,248,000 6,978,000
Sales, General and Admin. 11,542,000 11,748,000 12,371,000 19,185,000
Non-Recurring Items - - - -
Other - - - -
Operating Income 11,640,000 11,866,000 12,020,000 5,923,000
Income From Continuing Operations
Add'l Income/Expense Items 568,000 128,000 1,049,000 195,000
Earnings Before Interest and Tax 12,279,000 12,041,000 13,092,000 6,244,000
Interest Expense 1,270,000 1,313,000 1,242,000 1,301,000
Earnings Before Tax 11,009,000 10,728,000 11,850,000 4,943,000
Income Tax 1,688,000 3,124,000 3,450,000 2,042,000
Minority Interest 318,000 291,000 306,000 343,000
Equity Earnings Unconsolidated Subsidiary 71,000 47,000 23,000 127,000
Net Income Cont. Operations 9,075,000 7,360,000 8,117,000 2,685,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 9,003,000 7,313,000 8,094,000 2,558,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 9,003,000 7,313,000 8,094,000 2,558,000